( MENAFN - EIN Presswire) Pulmonary Valve Replacement market is projected to grow at a CAGR of 4.9% from 2023 to 2031 and reach more than US$ 1.6 Bn by the end of 2031 Atil Chaudhari Transparency ...

An Oklahoma baby is celebrating his first birthday two months after having a life-saving heart transplant. Parker Helmerich ...

A boy who spent nearly his entire first year of life hospitalized was able to celebrate his first birthday at home after ...

As the Iris Valve moves closer to real-world use, thousands of families may soon find relief. Their children may have a safer ...

The mother of the transplants advocate, Isobel Terry, said her daughter's transplant gave her six Christmases that the family ...

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of ...

Pulmonx (LUNG – Research Report) received a Hold rating and price target from Citi analyst Joanne Wuensch yesterday. The company’s shares ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases ... and a swivelling side port in its haemostasis valve to solve ...

The dvm360 editorial team is counting down our Top 20 news stories and articles of the year, from January 1, 2024, to ...

Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today the commercial availability of its Morph DNA ...

Shares in heart valve innovator Anteris Technologies (ASX:AVR) are trading on the US Nasdaq exchange after the pricing of its ...